Specific areas include:
- Studies of the effects of HIV infection and anti-viral HIV therapies on hematopoiesis and the hematopoietic microenvironment.
- Development of novel gene therapy approaches for treating HIV infection based on auto-transplantation of genetically modified hematopoietic stem cells.
- Impact of HIV infection and of anti-viral HIV therapies on immunosuppressive management for hematopoietic stem cell and organ transplantation.
For more information, contact Dr. Daniel Wright, Hematology Program Director..
